Page last updated: 2024-10-29

imipramine and Hepatic Failure

imipramine has been researched along with Hepatic Failure in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities."5.29Hepatic failure associated with imipramine therapy. ( Ilan, Y; Reynes, M; Samuel, D; Tur-Kaspa, R, 1996)
"Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities."1.29Hepatic failure associated with imipramine therapy. ( Ilan, Y; Reynes, M; Samuel, D; Tur-Kaspa, R, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ilan, Y1
Samuel, D1
Reynes, M1
Tur-Kaspa, R1

Other Studies

1 other study available for imipramine and Hepatic Failure

ArticleYear
Hepatic failure associated with imipramine therapy.
    Pharmacopsychiatry, 1996, Volume: 29, Issue:2

    Topics: Antidepressive Agents, Tricyclic; Humans; Imipramine; Liver Failure; Male; Middle Aged

1996